Vanguard Group’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $443M | Sell |
|
|||||
|
2025
Q1 | $411M | Sell |
|
|||||
|
2024
Q4 | $522M | Buy |
|
|||||
|
2024
Q3 | $481M | Buy |
|
|||||
|
2024
Q2 | $86.6M | Buy |
|
|||||
|
2024
Q1 | $85.4M | Buy |
|
|||||
|
2023
Q4 | $79.5M | Buy |
|
|||||
|
2023
Q3 | $65.4M | Buy |
|
|||||
|
2023
Q2 | $21.8M | Buy |
|
|||||
|
2023
Q1 | $13.1M | Buy |
|
|||||
|
2022
Q4 | $13.2M | Buy |
|
|||||
|
2022
Q3 | $5.07M | Buy |
|
|||||
|
2022
Q2 | $6.17M | Buy |
|
|||||
|
2022
Q1 | $6.52M | Buy |
|
|||||
|
2021
Q4 | $11.7M | Buy |
|